FindTrial
Sign In

ROLE OF KETAMINE AS A TREATMENT MODALITY IN ALCOHOL DEPENDENCE SYNDROME PATIENTS

ROLE OF KETAMINE AS AN INTERVENTION IN ALCOHOL DEPENDENCE SYNDROME

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052559
Enrollment
60
Registered
2023-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

Intervention1: Ketamine: Ketamine, an effective potential therapy for ADS, is an antagonist of the N-methyl-D-aspartate receptor.Given that ketamine has antidepressant effects, there is some evidence

Sponsors

JSS hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Eligible participants has to be 20-50 years old Meet ICD - 10 criteria for ADS currently abstinent from alcohol Total Bilurubin less than 2 mg/dl

Exclusion criteria

Exclusion criteria: Patient in Delirium uncontrolled hypertension (systolic blood pressure 140 mmHg and diastolic blood pressure 90 mmHg) and the use of antihypertensives known case of Epilepsy a diagnosis of any current or past psychiatric disorder (except for depression, anxiety or alcohol dependence)

Design outcomes

Primary

MeasureTime frame
ketamine in combination with motivational enhance- ment therapy may be an effective pharmacotherapy for maintaining abstinence from alcoholTimepoint: 3 months - monthly follow ups—

Secondary

MeasureTime frame
Ketamine may be a better agent than Baclofen in maintaining abstinence from alcoholTimepoint: At the end of 3 months—

Countries

India

Contacts

Public ContactDr Venkatesh

JSS medical College ,Mysuru

rajeshraman@jssuni.edu.in9538553945

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026